Equities Research Analysts’ Updated EPS Estimates for July 14th (ABEO, ANSS, APA, BBY, BKS, CLF, CORZ, CRM, CRWD, CRWV)

Equities Research Analysts’ updated eps estimates for Monday, July 14th:

Abeona Therapeutics (NASDAQ:ABEO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $20.00 price target on the stock.

ANSYS (NASDAQ:ANSS) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $396.00 price target on the stock, up from their previous price target of $349.00.

APA (NASDAQ:APA) had its neutral rating reaffirmed by analysts at UBS Group AG. They currently have a $19.00 target price on the stock, up from their previous target price of $18.00.

Best Buy (NYSE:BBY) had its neutral rating reiterated by analysts at Piper Sandler. The firm currently has a $75.00 target price on the stock, down from their previous target price of $82.00.

Beeks Financial Cloud Group (LON:BKS) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 335 ($4.52) target price on the stock.

Cleveland-Cliffs (NYSE:CLF) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a $7.50 target price on the stock.

Core Scientific (NASDAQ:CORZ) had its market perform rating reaffirmed by analysts at JMP Securities. The firm currently has a $15.00 target price on the stock.

Salesforce (NYSE:CRM) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $275.00 price target on the stock.

CrowdStrike (NASDAQ:CRWD) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $495.00 price target on the stock, up from their previous price target of $490.00.

CoreWeave (NASDAQ:CRWV) had its neutral rating reiterated by analysts at HC Wainwright.

Dave (NASDAQ:DAVE) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $320.00 price target on the stock.

Dunelm Group (LON:DNLM) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 1,280 ($17.26) price target on the stock.

Domino’s Pizza (NASDAQ:DPZ) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $550.00 target price on the stock.

ECO Animal Health Group (LON:EAH) had its buy rating reissued by analysts at Shore Capital. Shore Capital currently has a GBX 150 ($2.02) price target on the stock.

Elevance Health (NYSE:ELV) had its buy rating reaffirmed by analysts at UBS Group AG. They currently have a $484.00 price target on the stock, down from their previous price target of $555.00.

Fluence Energy (NASDAQ:FLNC) had its neutral rating reiterated by analysts at Mizuho. The firm currently has a $10.00 price target on the stock, up from their previous price target of $6.00.

TechnipFMC (NYSE:FTI) had its neutral rating reiterated by analysts at BTIG Research.

Grove Collaborative (NYSE:GROV) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $1.20 price target on the stock.

The Goldman Sachs Group (NYSE:GS) had its market perform rating reaffirmed by analysts at JMP Securities. The firm currently has a $600.00 target price on the stock.

The Goldman Sachs Group (NYSE:GS) had its market perform rating reissued by analysts at Citizens Jmp.

Gore Street Energy Storage Fund (LON:GSF) had its house stock rating reissued by analysts at Shore Capital.

Henry Schein (NASDAQ:HSIC) had its neutral rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $72.00 target price on the stock, down from their previous target price of $82.00.

Itron (NASDAQ:ITRI) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $155.00 price target on the stock, up from their previous price target of $133.00.

ITV (LON:ITV) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co..

KKR & Co. Inc. (NYSE:KKR) had its market perform rating reissued by analysts at JMP Securities. The firm currently has a $150.00 target price on the stock.

Lear (NYSE:LEA) had its neutral rating reiterated by analysts at UBS Group AG. They currently have a $116.00 target price on the stock, up from their previous target price of $95.00.

Liontrust Asset Management (LON:LIO) had its underperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 310 ($4.18) target price on the stock.

Lemonade (NYSE:LMND) had its underweight rating reiterated by analysts at Morgan Stanley. Morgan Stanley currently has a $26.00 price target on the stock, up from their previous price target of $24.00.

Netflix (NASDAQ:NFLX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $1,400.00 target price on the stock.

Nextracker (NASDAQ:NXT) had its neutral rating reiterated by analysts at Mizuho. They currently have a $65.00 target price on the stock, down from their previous target price of $67.00.

Oscar Health (NYSE:OSCR) had its neutral rating reiterated by analysts at Piper Sandler. The firm currently has a $14.00 price target on the stock.

OS Therapies (NYSE:OSTX) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $20.00 price target on the stock.

Procter & Gamble (NYSE:PG) had its in-line rating reissued by analysts at Evercore ISI. The firm currently has a $170.00 price target on the stock, down from their previous price target of $190.00.

Polar Capital (LON:POLR) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 560 ($7.55) price target on the stock.

Perella Weinberg Partners (NASDAQ:PWP) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $23.00 price target on the stock, up from their previous price target of $22.00.

Radian Group (NYSE:RDN) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a $38.00 target price on the stock, up from their previous target price of $36.00.

Shoals Technologies Group (NASDAQ:SHLS) had its neutral rating reissued by analysts at Mizuho. They currently have a $7.00 price target on the stock.

SoFi Technologies (NASDAQ:SOFI) had its market perform rating reiterated by analysts at Citizens Jmp.

SoFi Technologies (NASDAQ:SOFI) had its market perform rating reiterated by analysts at JMP Securities. The firm currently has a $17.00 target price on the stock.

SoundHound AI (NASDAQ:SOUN) had its neutral rating reiterated by analysts at Piper Sandler. The firm currently has a $12.00 target price on the stock.

Thor Explorations (LON:THX) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 38 ($0.51) target price on the stock.

Texas Instruments (NASDAQ:TXN) had its buy rating reiterated by analysts at UBS Group AG. UBS Group AG currently has a $255.00 price target on the stock, up from their previous price target of $245.00.

Touchstone Exploration (LON:TXP) had its house stock rating reaffirmed by analysts at Shore Capital.

Urgent.ly (NASDAQ:ULY) had its buy rating reaffirmed by analysts at Chardan Capital. They currently have a $15.00 price target on the stock.

US Foods (NYSE:USFD) had its overweight rating reiterated by analysts at Morgan Stanley. The firm currently has a $89.00 price target on the stock, up from their previous price target of $84.00.

Valero Energy (NYSE:VLO) had its peer perform rating reissued by analysts at Wolfe Research.

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) had its neutral rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $107.00 target price on the stock, up from their previous target price of $90.00.

Vestis (NYSE:VSTS) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $6.00 price target on the stock, up from their previous price target of $5.00.

Warner Bros. Discovery (NASDAQ:WBD) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $18.00 price target on the stock.